(Q36106855)

12 August 2017

1 reference

title

Inflammatory processes and Alzheimer's disease (English)

1 reference

12 August 2017

0 references

2

Paul S Aisen

1 reference

12 August 2017

Sally Walsh

1

1 reference

12 August 2017

1 September 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

5

1 reference

12 August 2017

793-798

1 reference

Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

12 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Translating cell biology into therapeutic advances in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

The importance of inflammatory mechanisms for the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Microglia and the immune pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimer's disease: are they protective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.5.793

21 January 2018

Identifiers

DOI

10.1586/14737175.4.5.793

1 reference

12 August 2017

1 reference

PubMed ID

15853506